CytomX Therapeutics vs Whitehawk Therapeutics
CTMX and WHWK side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CTMX and WHWK compare
CytomX Therapeutics is the larger company, worth 2.4 times as much as Whitehawk Therapeutics ($423M against $176M).
CytomX Therapeutics grew revenue faster over the last twelve months (−87.0% versus −100% for Whitehawk Therapeutics).
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CTMX | WHWK |
|---|---|---|
| Size and price | ||
| Market cap | $423M | $176M |
| Share price | $1.94 | $3.08 |
| Change, 1 year | −50.0% | 43.9% |
| Change, 5 years | −71.3% | −86.3% |
| Beta (5Y) | 1.55 | 2.33 |
| Employees | 69 | 23 |
| StockData Score | ||
| Total score | 8 | 8 |
| Valuation score | 1 | 1 |
| Growth score | 1 (better) | 0 |
| Performance score | 1 | 1 |
| Health score | 5 | 6 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 23.1× | – |
| P/B | 1.4× | 1.0× (better) |
| FCF yield | −19.5% (better) | −39.5% |
| Growth | ||
| Revenue growth (TTM) | −87.0% (better) | −100% |
| Revenue growth, 5Y average | 2.2% (better) | −12.6% |
| Net income growth (TTM) | −266% | – |
| EPS growth (TTM) | −179% | – |
| Profitability | ||
| Operating margin | −476% | – |
| Net margin | −435% | – |
| FCF margin | −451% | – |
| Return on equity | −37.8% (better) | −45.0% |
| Financial health | ||
| Debt / equity | 0.00 | 0.00 |
| Current ratio | 9.36 | 17.38 (better) |
| Altman Z-score | 0.79 | 6.35 (better) |
| Piotroski F-score | 2 | 4 (better) |
| Dividends and buybacks | ||
| Buyback yield | −57.9% | – |
| Shareholder yield | −57.9% | 0.00% (better) |
| Ownership | ||
| Held by institutions | 97.9% | 75.8% |
| Held by insiders | 1.5% | 49.9% |
| Insider net buying, 12 months | −$1.2M (better) | −$2.6M |
| Short interest, % of float | 21.1% | 8.7% |
Go deeper
- CTMX stock overview
- CTMX income statement
- CTMX valuation and score
- WHWK stock overview
- WHWK income statement
- WHWK valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.